Corneal Collagen Cross-Linking With Riboflavin
To assess the 10-year follow-up efficacy and safety of riboflavin ultraviolet A-induced cross-linking (CXL) in a population of pediatric patients aged 18 years and younger with progressive keratoconus (KC).
Južne Vesti
Treatment of keratoconus in Laser focus.